UrgoKTwo with UrgoStart
Two-layer compression bandaging kit that combines UrgoKTwo with UrgoStart Contact.
The professional's guide to wound product selection
The professional's guide to wound product selection
Two-layer compression bandaging kit that combines UrgoKTwo with UrgoStart Contact.
A highly absorbent sterile dressing composed of 'G- type' calcium alginate fibres and hydrocolloid particles.
A highly absorbent antibacterial sterile silver dressing, that is also composed of 'G- type' calcium alginate fibres and hydrocolloid particles.
Soft-absorbent foam dressing containing a protease inhibitor (TLC-NOSF Healing Matrix). The TLC-NOSF Healing Matrix inhibits matrix metalloproteinases and promotes the formation of new blood vessels. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Soft-absorbent adhesive foam dressing containing a protease inhibitor (TLC-NOSF) with a vapour permeable backing and silicone adhesive border. The TLC-NOSF Healing Matrix inhibits matrix metalloproteinases promotes angiogenesis. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Flexible non-occlusive contact layer containing a protease inhibitor (TLC-NOSF) that inhibits matrix metalloproteinases and promotes the formation of new blood vessels. Use with a secondary absorbent dressing for exuding wounds. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
A polyabsorbent fibre pad containing a protease inhibitor (TLC-NOSF Healing Matrix), polyabsorbent fibres, a superabsorbent layer and a silicone border with waterproof backing. The TLC-NOSF Healing Matrix inhibits matrix metalloproteinases and promotes the formation of new blood vessels. The polyabsorbent fibres bind, trap and retain exudate, slough and debris. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
A polyabsorbent fibre pad containing a protease inhibitor (TLC-NOSF Healing Matrix) and polyabsorbent fibres. The TLC-NOSF Healing Matrix inhibits excess metalloproteinases and promotes angiogenesis. The polyabsorbent fibres bind, trap and retain exudate, slough and debris. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Flexible contact layer containing the TLC (technology lipido-colloid) healing matrix to provide a nurturing environment for healing and harm-free care.
A soft-adherent foam featuring the TLC (technology lipido-colloid) healing matrix to provide a nurturing environment for healing and harm-free care.